Absci Corporation to Present at 44th Annual J.P. Morgan Healthcare Conference.

Absci Corporation, a clinical-stage biopharmaceutical company, will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco. Absci management will present on January 14th at 3:45 p.m. Pacific Time, and the presentation will be accessible on the company's investor relations website. Absci is advancing drug discovery with generative design and an Integrated Drug Creation platform that combines AI models with a synthetic biology data engine.